Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Taylor BL, Matrai CE, Smith AL, Ayangbesan A, Xia L, Golombos DM, et al. Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? Clin Genitourin Cancer. 2019;17(1):e209-e215.

Lee JY, Schizas M, Geyer FC, Selenica P, Piscuoglio S, Sakr RA, et al. Lobular Carcinomas Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma. Clin Cancer Res. 2019;25(2):674-686.

Farooq A, Goyal A, Giorgadze T, Scherr G, Evans JJ, Hartley CP. Cytomorphological features of glomus tumors arising in the stomach: A series of two cases diagnosed on FNA. Ann Diagn Pathol. 2019;42:42-47.

Goel R, Vasovic LV, Westblade LF, Harris R, D'Ambrosio D, Emmons F, et al. The power of a trained eye: fatal transfusion-transmitted anaplasmosis and a case study in investigative work. Transfusion. 2019;59(2):444-445.

Wang Y, Lu S, Xiong J, Singh K, Hui Y, Zhao C, et al. ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix. J Pathol Clin Res. 2019;5(1):40-52.

Irey EA, Lassiter CM, Brady NJ, Chuntova P, Wang Y, Knutson TP, et al. JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proc Natl Acad Sci U S A. 2019;116(25):12442-12451.

Hissong E, Fernandes H, Jessurun J. Colonic Mucosa With Polypoid Hyperplasia. Am J Clin Pathol. 2019;152(4):423-430.

Roe CJ, Siddiqui MT, Lawson D, Cohen C. RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry. Appl Immunohistochem Mol Morphol. 2019;27(2):155-159.

Zadra G, Loda M. When fat goes down, prostate cancer is on the ropes. Mol Cell Oncol. 2019;6(3):1595308.

Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, et al. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res. 2019;25(4):1280-1290.